ferrous sulfate
PolandDrugs containing this active substance
-
The medicinal product is used in the treatment of iron deficiency anaemia and latent iron deficiency, as well as for prophylaxis during pregnancy. It is intended for adults and children over 12 years of age.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AE10
Manufacturer: EGIS PHARMACEUTICALS PLC
-
The medicinal product is used for the treatment of iron deficiency anaemia and latent iron deficiency, as well as for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: EGIS Pharmaceuticals PLC
-
The medicinal product is used for the treatment of iron deficiency anaemia, the treatment of latent iron deficiency, and for prophylaxis during pregnancy. It is intended for adults and children over 12 years of age.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used to treat iron deficiency anemia and latent iron deficiency, as well as for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AE10
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used to treat iron deficiency anemia and latent iron deficiency, as well as for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used to treat iron deficiency anemia, to treat latent iron deficiency, and for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicinal product is used in the treatment of iron deficiency anaemia and latent iron deficiency, as well as for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicinal product is used in the treatment of iron deficiency anemia and latent iron deficiency, as well as for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicinal product is used for the treatment of iron deficiency anaemia, the treatment of latent iron deficiency, and for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicinal product is used in the treatment of iron deficiency anemia and latent iron deficiency, as well as for prophylaxis during pregnancy.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient). It is intended for adults and children over 10 years of age.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Ibérica, S.A.
-
It is used for the treatment of anemia resulting from iron deficiency and for the prevention of iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Iberica, S.A.
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women whose diet is insufficient. It is intended for adults and children over 10 years of age.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Ibérica, S.A.
-
It is used in the treatment of iron deficiency anemia and in the prevention of iron deficiency (prophylaxis), for example in pregnant women with insufficient iron intake in their diet.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Medicament
-
It is used in the treatment of iron deficiency anemia and in the prevention of iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency (prophylaxis), for example in pregnant women with insufficient iron intake in their diet.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
It is used in the treatment of iron deficiency anemia and in the prevention of iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
It is used in the treatment of iron deficiency anemia and in the prevention of iron deficiency (prophylaxis), for example in pregnant women with insufficient iron intake in their diet.
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient).
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Iberica, S.A.
-
It is used in the treatment of iron deficiency anemia and in the prevention of iron deficiency in pregnant women whose diet is insufficient. It is indicated for adults and children over 10 years of age.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient). It is intended for adults and children over 10 years of age.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Iberica, S.A.
-
The medicine is used to treat iron deficiency anemia and to prevent iron deficiency (prophylaxis), for example in pregnant women with insufficient iron intake in their diet.
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg ATC: B03AA07
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD
Manufacturer: Pierre Fabre Farmaka A.E.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, film-coated, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Farmaka A.E.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC: B03AD03
Manufacturer: Pierre Fabre Medicament